Entera Bio Ltd. — Director's Dealing 2022

Jan 21, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: JAMAS SPIROS (Director, Chief Executive Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.24	2031-01-04	Ordinary Shares, par value NIS 0.0000769 per share (1314218)		Direct

Footnotes

F1: The options vest over a four-year period commencing on January 4, 2021, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.